Physician profile
Sam Stokes
NPI 1558452144
$1,994.04
in general payments reported to CMS, 2019-2025
25 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $133 · 2021: $210 · 2022: $86.06 · 2023: $256 · 2024: $758 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.19 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $373.34 | 2020-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Medtronic, INC. | $235.03 | 2021-2024 | Interstim |
| Astellas Pharma US INC | $187.75 | 2019-2024 | Myrbetriq, Xtandi |
| Teleflex LLC | $181.16 | 2024 | Urolift |
| Boston Scientific Corporation | $135.15 | 2019-2021 | |
| Janssen Biotech, INC. | $132.93 | 2023-2025 | Erleada |
| Abbvie INC. | $131.33 | 2022-2025 | Botox |
| Myovant Sciences INC. | $90.89 | 2021 | |
| Pfizer INC. | $64.08 | 2023-2024 | |
| Karl Storz Endoscopy-America | $63.79 | 2024 | Hopkins |
| Becton, Dickinson and Company | $52.45 | 2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $49.55 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $43.69 | 2023-2024 | Lynparza, Keytruda, Welireg |
| Novartis Pharmaceuticals Corporation | $32.78 | 2024-2025 | |
| Antares Pharma, INC. | $31.34 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $23.75 | 2019 | |
| Laborie Medical Technologies Corp. | $23.54 | 2023 | |
| Procept Biorobotics Corporation | $21.96 | 2024 | Aquabeam System |
| Travere Therapeutics, INC. | $21.38 | 2019 | |
| Myriad Genetic Laboratories, INC. | $19.86 | 2022 | |
| Progenics Pharmaceuticals, INC. | $18.59 | 2024 | |
| Photocure INC | $17.00 | 2024 | Cysview |
| Coloplast Corp | $15.02 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.18 | 2020 | |
| Zyla Life Sciences, INC. | $13.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.